Nath Bio-Genes (I)

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue25.3645.18235.4022.6331.78
Expenses23.3243.35201.7720.6829.55
EBITDA5.674.3437.155.155.82
EBIT5.003.3536.384.395.06
Profit Before Tax2.051.8233.621.954.73
Net Profit1.351.5933.401.603.96
Financial Ratios
Operating Profit Margin22.41%9.66%15.79%22.82%26.21%
Net Profit Margin5.34%3.54%14.20%7.09%4.60%
Earning Per Share (Diluted)0.710.8417.580.852.09
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ